Literature DB >> 27670761

T-lymphoid progenitors - we know what they are, but know not what they may be.

Lars Bullinger1.   

Abstract

Mesh：

Year:  2016        PMID： 27670761      PMCID： PMC5109240          DOI： 10.15252/embj.201695613

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  10 in total

1.  Dendritic cell potentials of early lymphoid and myeloid progenitors.

Authors:  M G Manz; D Traver; T Miyamoto; I L Weissman; K Akashi
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

2.  Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Authors:  Bas J Wouters; Meritxell Alberich Jordà; Karen Keeshan; Irene Louwers; Claudia A J Erpelinck-Verschueren; Dennis Tielemans; Anton W Langerak; Yiping He; Yumi Yashiro-Ohtani; Pu Zhang; Christopher J Hetherington; Roel G W Verhaak; Peter J M Valk; Bob Löwenberg; Daniel G Tenen; Warren S Pear; Ruud Delwel
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

3.  Adult T-cell progenitors retain myeloid potential.

Authors:  Haruka Wada; Kyoko Masuda; Rumi Satoh; Kiyokazu Kakugawa; Tomokatsu Ikawa; Yoshimoto Katsura; Hiroshi Kawamoto
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

4.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Authors:  Shannon L Maude; Sibasish Dolai; Cristina Delgado-Martin; Tiffaney Vincent; Alissa Robbins; Arthavan Selvanathan; Theresa Ryan; Junior Hall; Andrew C Wood; Sarah K Tasian; Stephen P Hunger; Mignon L Loh; Charles G Mullighan; Brent L Wood; Michelle L Hermiston; Stephan A Grupp; Richard B Lock; David T Teachey
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

5.  E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.

Authors:  R P Bourette; M-F Grasset; G Mouchiroud
Journal:  Oncogene       Date:  2006-07-03       Impact factor: 9.867

6.  Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.

Authors:  Alireza Eghtedar; Srdan Verstovsek; Zeev Estrov; Jan Burger; Jorge Cortes; Carol Bivins; Stefan Faderl; Alessandra Ferrajoli; Gautam Borthakur; Solly George; Peggy A Scherle; Robert C Newton; Hagop M Kantarjian; Farhad Ravandi
Journal:  Blood       Date:  2012-03-15       Impact factor: 22.113

7.  Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

Authors:  Estella Matutes; Winfried F Pickl; Mars Van't Veer; Ricardo Morilla; John Swansbury; Herbert Strobl; Andishe Attarbaschi; Georg Hopfinger; Sue Ashley; Marie Christine Bene; Anna Porwit; Alberto Orfao; Petr Lemez; Richard Schabath; Wolf-Dieter Ludwig
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

8.  Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.

Authors:  Pia Riemke; Melinda Czeh; Josephine Fischer; Carolin Walter; Saeed Ghani; Matthias Zepper; Konstantin Agelopoulos; Stephanie Lettermann; Marie L Gebhardt; Nancy Mah; Andre Weilemann; Michael Grau; Verena Gröning; Torsten Haferlach; Dido Lenze; Ruud Delwel; Marco Prinz; Miguel A Andrade-Navarro; Georg Lenz; Martin Dugas; Carsten Müller-Tidow; Frank Rosenbauer
Journal:  EMBO J       Date:  2016-08-29       Impact factor: 11.598

Review 9.  Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells.

Authors:  Ashley Pandolfi; Laura Barreyro; Ulrich Steidl
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

10.  ETV6 mutations in early immature human T cell leukemias.

Authors:  Pieter Van Vlierberghe; Alberto Ambesi-Impiombato; Arianne Perez-Garcia; J Erika Haydu; Isaura Rigo; Michael Hadler; Valeria Tosello; Giusy Della Gatta; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Selina M Luger; Jacob M Rowe; Montserrat Rue; Adolfo A Ferrando
Journal:  J Exp Med       Date:  2011-12-12       Impact factor: 14.307
  10 in total
  1 in total

1.  Deregulated expression of circular RNAs in acute myeloid leukemia.

Authors:  Susanne Lux; Tamara J Blätte; Bernhard Gillissen; Antje Richter; Sibylle Cocciardi; Sabrina Skambraks; Klaus Schwarz; Hubert Schrezenmeier; Hartmut Döhner; Konstanze Döhner; Anna Dolnik; Lars Bullinger
Journal:  Blood Adv       Date:  2021-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.